Comparable stake leader
BlackRock, Inc.
SEC ownership of RxSight, Inc.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001111485.
Disclosed value leader
BlackRock, Inc.
Comparable rows
50/50
Latest evidence
17 Jun 2026
- Public ticker
- RXST on Nasdaq
- Parsed ownership sources
-
13D/G, 13F, and 3/4/5
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
BlackRock, Inc.
Ranking: Comparable ownership first, then disclosed value
- Comparable ownership rows
-
50 of 50
Meaning: Rows with safely comparable ownership %
- Latest 13D/G holder
-
BlackRock, Inc.
Source: Latest parsed Schedule 13D/G stake
- Latest parsed ownership date
-
17 Jun 2026
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001111485
- Issuer location
- Aliso Viejo, CA
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
3 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of RxSight, Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BlackRock, Inc.
Disclosed value leader
BlackRock, Inc.
Comparable rows
50/50
Latest evidence
17 Jun 2026
13D/G
13F
3/4/5
Lead comparable stake: 5.8%
13D/G row: BlackRock, Inc.
Showing 1-8 of 50 holder rows.
Quick read
BlackRock, Inc. leads the comparable SEC ownership view at 5.8%.
50 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BlackRock, Inc.'s linked filing trail.
Comparable ownership
Top 5
BlackRock, Inc.
5.8%
MILLENNIUM MANAGEMENT LLC
5.4%
Artisan Partners Limited Partnership
5%
Divisadero Street Capital Managem...
0.5%
BANK OF AMERICA CORP /DE/
0.4%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 50 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BlackRock, Inc. |
13D/G
13F
Company
|
5.8%
|
$21,515,668
2,393,289 shares
|
$0 | 30 Sep 2025 |
| MILLENNIUM MANAGEMENT LLC |
13D/G
13F
Company
|
5.4%
|
$19,715,627
2,193,062 shares
|
-$3,757,056 | 30 Sep 2025 |
| Artisan Partners Limited Partnership |
13D/G
13F
Artisan Partners Asset Management Inc. · Company
|
5%
|
$13,937,291
2,058,684 shares
|
-$667,387 | 31 Mar 2026 |
| Divisadero Street Capital Management, LP |
13D/G
|
0.5%
|
$1,751,344
218,918 shares
|
-$18,500,824 | 30 Jun 2025 |
| BANK OF AMERICA CORP /DE/ |
13F
13D/G
Company
|
0.4%
from 13D/G
|
$7,453,841
1,210,039 shares
|
— | 31 Mar 2026 |
| LORD, ABBETT & CO. LLC |
13D/G
|
0%
|
$25,262
1,715 shares
|
$0 | 31 Dec 2024 |
| Jesse Anderson Corley |
3/4/5
Director
|
0.26%
|
$666,172
108,145 shares
|
— | 17 Jun 2026 |
| William J. Link PhD |
3/4/5
Director
|
0.23%
|
$592,221
96,140 shares
|
— | 17 Jun 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 20 Jun 2025.
Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-20 of 21 reporting-owner rows connected to RxSight, Inc.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
21
Largest Forms 3/4/5 holder
RxSight I, LLC
Net 12M change
$0
Latest report
17 Jun 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| RxSight I, LLC | 10%+ Owner | $96,806,554 | Mixed | 03 Aug 2021 | ||
| Richard M. Wolfen | Director | $88,332,816 | Mixed | 03 Aug 2021 | ||
| Bruce C. Robertson | Director | $66,482,607 | Mixed | 03 Aug 2021 | ||
| Daniel Mark Schwartz | Director | $19,567,301 | Mixed | 03 Aug 2021 | ||
| RA CAPITAL MANAGEMENT, L.P. | 10%+ Owner | $10,265,312 | Mixed | 03 Aug 2021 | ||
| Eric Weinberg | Exhibit 24 - Power of Attorney Chief Business Development Officer | $4,697,521 | Mixed | 27 Feb 2026 | ||
| Jesse Anderson Corley | Director | $666,172 | Median | 17 Jun 2026 | ||
| William J. Link PhD | Director | $592,221 | Median | 17 Jun 2026 | ||
| Bakker Juliet Tammenoms | Director | $534,262 | Median | 17 Jun 2026 | ||
| Ilya Goldshleger | Chief Operating Officer | $490,047 | Median | 17 Apr 2026 | ||
| Julie Andrews | Director | $480,948 | Median | 17 Jun 2026 | ||
| Robert Keith Warner | Director | $480,948 | Median | 17 Jun 2026 | ||
| PALMISANO ROBERT J | Director | $480,948 | Median | 17 Jun 2026 | ||
| Tamara Fountain | Director | $447,105 | Median | 17 Jun 2026 | ||
| Raymond W. Cohen | Director | $409,837 | Median | 17 Jun 2026 | ||
| Shweta Maniar | Director | $339,859 | Median | 17 Jun 2026 | ||
| Shelley B. Thunen | Co-President and Chief Financial Officer | $166,403 | Mixed | 14 Apr 2025 | ||
| Scott Gaines | Chief Customer Officer | $112,993 | Mixed | 27 Feb 2026 | ||
| Mark Wilterding | Chief Financial Officer | $94,158 | Mixed | 28 Feb 2026 | ||
| Christopher Cox | Director | Mixed | 29 Jul 2021 |
Recent insider transactions for RxSight, Inc.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Robert Keith Warner | RXST | Common Stock | Award | 90.2% | 37,037 | 78,076 | 17 Jun 2026 | Direct | ||
| Palmisano Robert J | RXST | Common Stock | Award | 90.2% | 37,037 | 78,076 | 17 Jun 2026 | Direct | ||
| Shweta Maniar | RXST | Common Stock | Award | 204.2% | 37,037 | 55,172 | 17 Jun 2026 | Direct | ||
| Tamara Fountain | RXST | Common Stock | Award | 104.2% | 37,037 | 72,582 | 17 Jun 2026 | Direct | ||
| William J. Link PhD | RXST | Common Stock | Award | 97.8% | 37,037 | 74,892 | 17 Jun 2026 | Direct | ||
| Jesse Anderson Corley | RXST | Common Stock | Award | 75.3% | 37,037 | 86,227 | 17 Jun 2026 | Direct | ||
| Raymond W. Cohen | RXST | Common Stock | Award | 86.5% | 30,864 | 66,532 | 17 Jun 2026 | Direct | ||
| Bakker Juliet Tammenoms | RXST | Common Stock | Award | 76.9% | 37,037 | 85,183 | 17 Jun 2026 | Direct | ||
| Julie Andrews | RXST | Common Stock | Award | 90.2% | 37,037 | 78,076 | 17 Jun 2026 | Direct | ||
| Ilya Goldshleger | RXST | Common Stock | Options Exercise | 19% | 12,489 | 78,180 | 17 Apr 2026 | Direct | ||
| Ilya Goldshleger | RXST | Stock Option (right to buy) | Options Exercise | -100% | -12,489 | 5 | 17 Apr 2026 | Direct | ||
| Mark Wilterding | RXST | Common Stock | Tax liability | -39.5% | -8,068 | 12,373 | 28 Feb 2026 | Direct | ||
| Mark Wilterding | RXST | Common Stock | Options Exercise | 20,441 | 20,441 | 28 Feb 2026 | Direct | |||
| Mark Wilterding | RXST | Restricted Stock Unit | Options Exercise | -12.5% | -20,441 | 143,087 | 28 Feb 2026 | Direct | ||
| Scott Gaines | RXST | Common Stock | Tax liability | -14.8% | -2,580 | 14,848 | 28 Feb 2026 | Direct | ||
| Scott Gaines | RXST | Common Stock | Options Exercise | 56.1% | 6,261 | 17,428 | 28 Feb 2026 | Direct | ||
| Scott Gaines | RXST | Restricted Stock Unit | Options Exercise | -72.2% | -6,261 | 2,414 | 28 Feb 2026 | Direct | ||
| Scott Gaines | RXST | Restricted Stock Unit | Award | 32,218 | 32,218 | 27 Feb 2026 | Direct | |||
| Ilya Goldshleger | RXST | Restricted Stock Unit | Award | 32,218 | 32,218 | 27 Feb 2026 | Direct | |||
| Eric Weinberg | RXST | Restricted Stock Unit | Award | 32,218 | 32,218 | 27 Feb 2026 | Direct | |||
| Ronald M. Kurtz MD | RXST | Restricted Stock Unit | Award | 80,545 | 80,545 | 27 Feb 2026 | Direct | |||
| Mark Wilterding | RXST | Restricted Stock Unit | Award | 163,528 | 163,528 | 12 Jan 2026 | Direct | |||
| Mark Wilterding | RXST | Stock Option (right to buy) | Award | 258,770 | 258,770 | 12 Jan 2026 | Direct | |||
| Ilya Goldshleger | RXST | Common Stock | Options Exercise | 55.5% | 23,445 | 65,691 | 25 Sep 2025 | Direct | ||
| Ilya Goldshleger | RXST | Stock Option (right to buy) | Options Exercise | -100% | -23,445 | 0 | 25 Sep 2025 | Direct | ||
| Raymond W. Cohen | RXST | Common Stock | Award | 35,668 | 35,668 | 31 Jul 2025 | Direct |
* marks a reported price that did not pass the local price check.